Background
The glucose analogue, 18 F-FDG, can be used to image inflammatory cell activity non-invasively by PET. In the present study, we investigate the possibility of using 18 F-FDG to characterize atherosclerotic plaques.
A 77-year-old man with symptomatic carotid atherosclerosis was imaged using 18 F-FDG-PET and co-registered MRI. A plaque with intense fibrotic and necrotic content was obtained. Due to the fact that the tissue showed up as inactive, according to the metabolic activity, it was not possible to observe 18 F-FDG uptake.
Our aim was to confirm that it could be clinically used to predict the inflammatory activity of the plaque.
Preface
Stroke is a serious public health problem, representing the leading cause of death (4.4 million deaths per year) and disability worldwide. Of the different causes of stroke, attention has been given to carotid atherosclerosis 1 . Atherothrombosis of the carotid bifurcation is responsible for approximately 30% of cerebral ischemic episodes 2 .
The atherosclerotic plaque composition, rather than the degree of arterial stenosis, appears to be a critical determinant of atherosclerotic plaque vulnerability and thrombogenicity 3 . The vulnerability of an atherosclerotic plaque to rupture is believed to be related to its intrinsic composition, such as the size of the lipid core and the presence of intraplaque hemorrhage.
The inflammatory process is significant in both the pathogenesis and outcome of atherosclerosis. Unstable plaques, containing numerous inflammatory cells, have a high risk of rupture 4, 5 .
The current "gold-standard" imaging technique for atherosclerosis is the x-ray contrast angiography, which provides high-resolution definition of the site and severity of luminal stenoses, but no information about plaque constitution. The information about the size of the plaque is not enough to differentiate between unstable and stable plaques and, therefore, it is unable to predict the risk of plaque rupture 6, 7 .
In order to examine the presence, extent and composition of atherosclerotic lesions in patients, there is a clinical need for a non-invasive diagnostic imaging technique which can be used to check the vulnerability of atherosclerotic plaques 6, 8 . This is a preliminary study that aims at investigating the possibility of using 18 F-FDG to characterize atherosclerotic plaque within carotid artery through PET (Positron Emission Tomography) technology with MRI (Magnetic Resonance Imaging) fusion.
Case Report
A 77-year-old non-diabetic, hypertensive, sedentary man, with coronary heart disease and family history of Carotid Vascular Disease (CVD), was submitted to a PET/MRI and Doppler examinations, previous to carotid surgery.
The Doppler was performed on an Acuson Antares equipment (Siemens, Mountain View, California, USA), with a linear transducer of 5-10Mz and color Doppler DR:55dB. The PET assessment was carried out using an ECAT EXACT 921/47 (Siemens, Knoxville, TN-USA) PET scanner, with a BGO crystal. We administered 8,92 mCi 18 F-FDG intravenously. The PET image was acquired in 3D mode, 2 bed position (6 min/bed), at 60 minutes after 18 F-FDG administration.
The examination was accomplished to allow a visualization of the carotid, and thus, the image was obtained from the top of the skull down to the emergence of the great vessels.
The PET image was reconstructed using an interactive algorithm with attenuation corrections using 68 Ga source.
This patient had an internal carotid artery stenosis of 76%, measured by MRI (using NASCET). The patient underwent MRI imaging for the purpose of locating the anatomical structures in the PET images. The MRI studies were performed on a 3.0T scanner (Magnetom Trio, Siemens-Erlangen, Germany Ten minutes after the intravenous administration of 0.2mmol/kg of gadodiamide (Dotaren™, Gerbet, France) images were obtained of the proximal portion of the left internal carotid artery in T 1 FS sequence (Figure 1 ).
The PET was co-registered with MRI imaging through a software system. Thus, anatomical structures identified by MRI imaging were correlated with 18 F-FDG PET images by a process of image co-registration. This work was approved by Ethical Committee of our Institution. The patient authorized the study and signed the Informed Consent Form.
An extensive uniform plaque with abnormal surfaces, which extended from the bifurcation to the proximal portion of the internal segment, was identified at the Doppler examination. Increased turbulence and high peak systolic velocity, which exceeded the maximum limit of Nyquist, suggested stenosis > 70%. The lumen diameter at the stenosis was 1.2 mm and 5.0 mm distal to the stenosis (post-plaque).
The MRI examination was carried out to provide anatomical information.
About 20 days after the examinations, the patient was submitted to carotid endarterectomy, with removal the atherosclerotic plaque. A plaque with intense fibrotic and necrotic content was obtained.
Due to the fact that the tissue appeared inactive, according to the metabolic activity, it was not possible to observe 18 F-FDG uptake at the PET examination.
Figure 1 -In vivo transverse imaging of a left internal carotid artery. A -T2-weighted image shows a high-signal intensity region (arrow white); B and C -T1 and T1-FS -weighted images show a high-signal intensity region (arrow black and yellow); D -Post contrast T1-FS -weighted image shows enhancement of a small region of the plaque (yellow and red arrows).

Discussion
Plaque composition has been associated with the onset of cerebral vascular disease. Pathological studies suggest that the development of stroke in carotid artery disease events depend, principally, on the composition and vulnerability of the plaques and at a lesser degree, on the severity of the stenosis. Rupture occurs preferentially in plaques containing a soft, lipid-rich core that is covered by a thin cap of fibrous tissue [5] [6] [7] .
The use of 18 F-FDG has been validated in Oncology 9 . The development of techniques to apply this radioisotope to others areas, such as Cardiology, has been the study purpose of many research centers.
Several studies with animal models have suggested that 18 F-FDG can accumulate in atherosclerotic plaque macrophages. Thus, 18 F-FDG might be used as a marker to quantify macrophages in atherosclerotic lesions and discriminate between unstable and stable plaques 6, 10 .
The fusion of the PET/MRI images has proven to be feasible, from the clinical viewpoint, due to the fact that carotids are fixed structures, in contrast to mobile organs, such as the liver and the lungs, which require manual adjustments ( Figure 2 ).
In this case report, the necrotic process of the atherosclerotic plaques was already installed and an intense fibrotic content was observed, reducing the inflammatory process and the metabolic activity of the tissue.
It was not possible to observe the uptake of 18 F-FDG in the macrophages due to the ignoble number of inflammatory cells and, consequently, there was no development of image through the PET methodology.
This was a preliminary study. Our research will be extended to other patients in order to evaluate different kinds of plaques, including those with the presence of macrophages and intense inflammatory processes.
18
F-FDG PET may be capable of imaging the plaque and potentially quantifying its inflammation degree. Moreover, 18 F-FDG PET could be used to predict the risk of future plaque rupture and to monitor the effects of atheroma-modifying therapies.
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